Organic light-emitting element
US-9466804-B2 · Oct 11, 2016 · US
US12063850B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12063850-B2 |
| Application number | US-202017060751-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 1, 2020 |
| Priority date | Dec 24, 2019 |
| Publication date | Aug 13, 2024 |
| Grant date | Aug 13, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An organometallic compound, wherein the organometallic compound has a C 2 symmetric structure, and is represented by Formula 1, wherein the sum of Δ(Ir—N) and Δ(Ir—C) is about 0.002 angstroms or less: Ir(L 1 ) 2 (L 2 ) Formula 1 wherein, in Formula 1, L 1 is a ligand represented by Formula 2 as provided herein, wherein one of two L 1 s is a first L 1 ligand and the other L 1 s is a second L 1 ligand and the first L 1 ligand and the second L 1 ligand are identical to each other, L 2 is a ligand represented by Formula 3 as provided herein, and Δ(Ir—N) and Δ(Ir—C) are as defined herein.
Opening claim text (preview).
What is claimed is: 1. An organometallic compound, wherein the organometallic compound has a C 2 symmetric structure, and is represented by Formula 1, wherein a sum of Δ(Ir—N) and Δ(Ir—C) is 0.002 angstroms or less: Ir(L 1 ) 2 (L 2 ) Formula 1 wherein, in Formula 1, L 1 is a ligand represented by Formula 2, wherein one of two L 1 s is a first L 1 ligand and the other L 1 s is a second L 1 ligand, and the first L 1 ligand and the second L 1 ligand are identical to each other, and L 2 is a ligand represented by Formula 3, wherein, in Formula 2, Y 1 is N, and Y 2 is C, ring CY 1 is a polycyclic group comprising three or more 6-membered rings that are condensed with each other, ring CY 2 is a C 5 -C 30 carbocyclic group or a C 1 -C 30 heterocyclic group, T 1 is a group having a para Hammett substituent constant (σ p ) that is greater than 0 and less than 0.5, b1 is an integer from 1 to 10, wherein, when b1 is 2 or more, two or more T 1 groups are identical to or different from each other, R 1 , R 2 and R 31 to R 33 are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, —SF 5 , a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 7 -C 60 arylalkyl group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted C 1 -C 60 heteroaryloxy group, a substituted or unsubstituted C 1 -C 60 heteroarylthio group, a substituted or unsubstituted C 2 -C 60 heteroarylalkyl group, a substituted or unsubstituted C 2 -C 60 alkylheteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —N(Q 1 )(Q 2 ), —Si(Q 3 )(Q 4 )(Q 5 ), —Ge(Q 3 )(Q 4 )(Q 5 ), —B(Q 6 )(Q 7 ), —P(═O)(Q 8 )(Q 9 ), or —P(Q 8 )(Q 9 ), a1 and a2 in Formula 2 are each independently an integer from 0 to 10, wherein, when a1 is 2 or more, two or more R 1 groups are identical to or different from each other, and when a2 is 2 or more, two or more R 2 groups are identical to or different from each other, * and *′ in Formulae 2 and 3 each indicate a binding site to Ir in Formula 1, Δ(Ir—N) is an absolute value of a difference between an Ir and Y 1 bond distance for the first L 1 ligand and an Ir and Y 1 bond distance for the second L 1 ligand in Formulae 1 and 2, Δ(Ir—C) is an absolute value of a difference between an Ir and Y 2 bond distance for the first L 1 ligand and an Ir and Y 2 bond distance for the second L 1 ligand in Formulae 1 and 2, two or more of R 1 groups in the number of a1 are optionally linked to each other to form a C 5 -C 30 carbocyclic group unsubstituted or substituted with at least one R 1a , or two or more of R 1 groups in the number of a1 are optionally linked to each other to form a C 1 -C 30 heterocyclic group unsubstituted or substituted with at least one R 1a , two or more of R 2 groups in the number of a2 are optionally linked to each other to form a C 5 -C 30 carbocyclic group unsubstituted or substituted with at least one R 1a , or two or more of R 2 groups in the number of a2 are optionally linked to each other to form a C 1 -C 30 heterocyclic group unsubstituted or substituted with at least one R 1a , two or more of R 1 and R 2 are optionally linked to each other to form a C 5 -C 30 carbocyclic group unsubstituted or substituted with at least one R 1a , or two or more of R 1 and R 2 are optionally linked to each other to form a C 1 -C 30 heterocyclic group unsubstituted or substituted with at least one R 1a , two or more of R 31 to R 33 are optionally linked to each other to form a C 5 -C 30 carbocyclic group unsubstituted or substituted with at least one R 1a , or two or more of R 31 to R 33 are optionally linked to each other to form a C 1 -C 30 heterocyclic group unsubstituted or substituted with at least one R 1a , R 1a is the same as defined in connection with R 1 , and a substituent of the substituted C 1 -C 60 alkyl group, the substituted C 2 -C 60 alkenyl group, the substituted C 2 -C 60 alkynyl group, the substituted C 1 -C 60 alkoxy group, the substituted C 3 -C 10 cycloalkyl group, the substituted C 1 -C 10 heterocycloalkyl group, the substituted C 3 -C 10 cycloalkenyl group, the substituted C 1 -C 10 heterocycloalkenyl group, the substituted C 6 -C 60 aryl group, the substituted C 6 -C 60 aryloxy group, the substituted C 6 -C 60 arylthio group, the substituted C 7 -C 60 arylalkyl group, the substituted C 1 -C 60 heteroaryl group, the substituted C 1 -C 60 heteroaryloxy group, the substituted C 1 -C 60 heteroarylthio group, the substituted C 2 -C 60 heteroarylalkyl group, the substituted C 2 -C 60 alkylheteroaryl group, the substituted monovalent non-aromatic condensed polycyclic group, and the substituted monovalent non-aromatic condensed heteropolycyclic group is each independently: deuterium, —F, —Cl, —Br, —I, —CD 3 , —CD 2 H, —CDH 2 , —CF 3 , —CF 2 H, —CFH 2 , a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, or a C 1 -C 60 alkoxy group; a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, or a C 1 -C 60 alkoxy group, each substituted with deuterium, —F, —Cl, —Br, —I, —CD 3 , —CD 2 H, —CDH 2 , —CF 3 , —CF 2 H, —CFH 2 , a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 7 -C 60 arylalkyl group, a C 1 -C 60 heteroaryl group, a C 1 -C 60 heteroaryloxy group, a C 1 -C 60 heteroarylthio group, a C 2 -C 60 heteroarylalkyl group, a C 2 -C 60 alkylheteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —N(Q 11 )(Q 12 ), —Si(Q 13 )(Q 14 )(Q 15 ), —Ge(Q 13 )(Q 14 )(Q 15 ), —B(Q 16 )(Q 17 ), —P(═O)(Q 18 )(Q 19 ), —P(Q 18 )(Q 19 ), or a combination thereof; a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, or a monovalent non-aromatic condensed heteropolycyclic group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, —CD 3 , —CD 2 H, —CDH 2 , —CF 3 , —CF 2 H, —C
Triplet emission · CPC title
characterised by the electroluminescent [EL] layers · CPC title
of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd · CPC title
containing organic luminescent materials · CPC title
Iridium compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.